|
|
Volumn 83, Issue 4, 1998, Pages 1080-1082
|
|
Calcimimetics - New drugs with the potential to control hyperparathyroidism
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCITONIN;
CALCIUM CHANNEL STIMULATING AGENT;
CALCIUM RECEPTOR;
GUANINE NUCLEOTIDE BINDING PROTEIN;
MEMBRANE RECEPTOR;
PARATHYROID HORMONE;
PARATHYROID HORMONE RECEPTOR;
PLACEBO;
UNCLASSIFIED DRUG;
BONE MARROW CELL;
CALCIUM METABOLISM;
CALCIUM TRANSPORT;
CLINICAL TRIAL;
EDITORIAL;
GENE MUTATION;
HENLE LOOP;
HUMAN;
HYPERCALCEMIA;
HYPOCALCIURIA;
PRIMARY HYPERPARATHYROIDISM;
PRIORITY JOURNAL;
THYROID PARAFOLLICULAR CELL;
BONE DENSITY;
CALCIUM;
CALCIUM-BINDING PROTEINS;
HUMANS;
HYPERPARATHYROIDISM;
|
|
EID: 0031732732
PISSN: 0021972X
EISSN: None
Source Type: Journal
DOI: 10.1210/jc.83.4.1080 Document Type: Editorial |
|
Times cited : (17)
|
|
References (13)
|
